This is from the 5th paragraph of the Insider Fina
Post# of 148190
(Total Views: 784)
Posted On: 11/18/2021 11:42:24 AM
This is from the 5th paragraph of the Insider Financial article:
"Investors realize that a completed BLA filing under rolling review is almost as good as an approval when safety is not a factor, as is the case with leronlimab."
Can those with knowledge on rolling reviews please comment on whether this is true or just hyperbole? I've been on this message board for 18 months and I've never heard this idea expressed before. TIA, Ganesha
"Investors realize that a completed BLA filing under rolling review is almost as good as an approval when safety is not a factor, as is the case with leronlimab."
Can those with knowledge on rolling reviews please comment on whether this is true or just hyperbole? I've been on this message board for 18 months and I've never heard this idea expressed before. TIA, Ganesha
(1)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼